Archive for August, 2011

Kuros Completes Patient Recruitment in a Phase IIb Clinical Trial With KUR-211 for Diabetic Foot Ulcers

ZURICH, Switzerland, September 1, 2011 /PRNewswire/ -- Study Assessing the Safety and Efficacy of KUR-211 Expected to Report in mid 2012 Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products...
READ THE FULL ARTICLE >>

Mehr Fördergelder für Erforschung von Blutkrankheiten retten Leben

BRÜSSEL, September 1, 2011 /PRNewswire/ -- Die Erforschung von Krankheiten im Zusammenhang mit Blut rettet und verbessert Jahr für Jahr die Leben von Millionen von EU-Bürgern. Da dies allerdings nicht genügend Beachtung findet, fließen...
READ THE FULL ARTICLE >>

Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™

MELBOURNE, Australia, Aug. 31, 2011 /PRNewswire-Asia/ -- Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase 2b clinical study to confirm the efficacy of its novel head lice treatment DeOvo™. This Phase 2b trial is evaluating the...
READ THE FULL ARTICLE >>

Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®

MALVERN, Pa. and LYNBROOK, N.Y., Aug. 31, 2011 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, and BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company, today announced that they have dismissed all...
READ THE FULL ARTICLE >>

ZINO Society, ZZIF Companies Announced

SEATTLE, Aug. 31, 2011 /PRNewswire/ -- ZINO Society's 6th Annual ZINO Zillionaire Investment Forum (ZZIF), September 13, 2011, 8am-4pm at the Museum of History & Industry, Seattle. ZINO Zillionaire Investment Forum will showcase 35+ entrepreneurs from seed, early-stage and...
READ THE FULL ARTICLE >>

Star Scientific bringt Nahrungsergänzungsmittel Anatabloc™ auf den Markt

GLEN ALLEN, Virginia, August 31, 2011 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: CIGX) hat bekannt gegeben, dass das Unternehmen sich freut, die heutige Markteinführung von Anatabloc™ bekannt zu geben, einem Nahrungsergänzungsmittel, das das Immunsystem...
READ THE FULL ARTICLE >>

Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®

...
READ THE FULL ARTICLE >>

Healthcare Uniforms Carry Dangerous Bacteria

JERUSALEM, Israel—More than 60 percent of hospital nurses’ and doctors’ uniforms tested positive for potentially dangerous bacteria, according to a study published in the September issue of the American Journal of Infection Control. ...
READ THE FULL ARTICLE >>

CMS Releases ePrescribing Final Rule

Editor’s Note: On Aug. 31, the Centers for Medicare & Medicaid Services (CMS) released a final rule regarding the Medicare Electronic Prescribing (eRx) Incentive Program. The following is a news release CMS released reviewing the major points of ...
READ THE FULL ARTICLE >>

BioSante Pharmaceuticals, Inc. Selected For “100 Great Investigational Drugs”

...
READ THE FULL ARTICLE >>
« Older Entries
Get Adobe Flash playerPlugin by wpburn.com wordpress themes